Pharmacist intervention to improve adherence to medication among heart failure patients at North East Ethiopia hospital
Pharmacology Research & Perspectives · 2024-06 · 12 (3)
DOI: 10.1002/prp2.1199 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, online erschienen am 30.04.2024. Verfasst von Abate Wondesen Tsige und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, College of Health Sciences, Debre Berhan University, Debre Berhan, Ethiopia. Hauptthemen laut MEDLINE: Heart Failure, Pharmacists, Drug Monitoring. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Heart failure (HF) is a major and growing medical problem and its management is still challenging due to the coexistence of complications, co‐morbidity, and medication non‐adherence. HF patients who are adherent to their medication have fewer HF exacerbations, improved survival, and lower healthcare expenditure. Adherence to HF medication plays a pivotal role in attaining maximal therapeutic outcomes. The aim was to assess the medication adherence of heart failure patients at Debre Berhan Comprehensive Specialized Hospital (DBCSH). A pre‐post interventional study was undertaken from July 1, 2022, to December 31, 2022, at the medical referral clinic of DBCSH. The educational interventions were provided for 6 months. Medication adherence was determined using the Morisky Green Levin Medication Adherence Scale (MGLS). The data was entered into Epidata version 4.2.0 and analyzed using SPSS version 25.0 statistical software. Descriptive statistics and binary logistic regression analysis were performed. The strength of the association between predictor variables and outcome variables was determined using a 95% confidence interval and adjusted odd ratio. In the pre‐intervention phase, 54.6% of patients had medium medication adherence, while in the post‐intervention phase, 36.4% of patients had high medication adherence and 61.9% of patients had medium medication adherence. Following the intervention, medication cost (120, 50%), inadequate availability of drugs (75, 31%), and forgetfulness (30, 13%) were the main reasons for medication non‐adherence. The presence of co‐morbidity and the number of co‐morbidity ( p < .05) were significantly associated with the occurrence of decreased medication adherence in the pre‐intervention phase. Interventions by pharmacists to educate HF patients about the nature of their disease and providing brochures to increase awareness of their medications have been shown to improve medication adherence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, College of Health Sciences, Debre Berhan University, Debre Berhan, Ethiopia.
- Department of Pharmacy, Tirunesh-Beijing Hospital, Addis Ababa, Ethiopia.
- Department of Midwifery, School of Nursing and Midwifery, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
ORCID-Profile: Abate Wondesen Tsige, Siraye Genzeb Ayele
Zitieren
APA
Tsige, A. W., Kotiso, T. A., Ayenew, K. D., & Ayele, S. G. (2024). Pharmacist intervention to improve adherence to medication among heart failure patients at North East Ethiopia hospital. Pharmacology Research & Perspectives, 12(3). https://doi.org/10.1002/prp2.1199
Vancouver
Tsige AW, Kotiso TA, Ayenew KD, Ayele SG. Pharmacist intervention to improve adherence to medication among heart failure patients at North East Ethiopia hospital. Pharmacology Research & Perspectives. 2024;12(3). doi:10.1002/prp2.1199
BibTeX
@article{Tsige2024,
author = {Tsige, Abate Wondesen and Kotiso, Tsegaye Ababiya and Ayenew, Kassahun Dires and Ayele, Siraye Genzeb},
title = {Pharmacist intervention to improve adherence to medication among heart failure patients at North East Ethiopia hospital},
journal = {Pharmacology Research & Perspectives},
year = {2024},
volume = {12},
number = {3},
doi = {10.1002/prp2.1199}
}
EUVIMED